trending Market Intelligence /marketintelligence/en/news-insights/trending/jT98L1PmRi85xqXyN-QmDw2 content esgSubNav
In This List

Novavax names chief business officer/CFO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Novavax names chief business officer/CFO

Novavax Inc. promoted John Trizzino to senior vice president, chief business officer and CFO.

Trizzino, who originally joined Novavax in 2009, has been serving as senior vice president of commercial operations since 2014.

Novavax President and CEO Stanley Erck had been performing CFO duties on an interim basis after Barclay Phillips stepped down Nov. 10, 2017.

Novavax is a Gaithersburg, Md.-based clinical-stage biotechnology company that focuses on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.